Inovio Pharmaceuticals, Inc. (Nasdaq: INO) announced it has initiated a clinical study of its preventive Zika vaccine (GLS-5700) in 160 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE